MicroPort Scientific Corporation

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, SEMHF has a market cap of 45.4B. Regarding current trading prices, MCRPF is priced at $1.14, while SEMHF trades at $40.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas SEMHF's P/E ratio is 18.27. In terms of profitability, MCRPF's ROE is +0.06%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, MCRPF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check SEMHF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, RYLPF has a market cap of 25.9B. Regarding current trading prices, MCRPF is priced at $1.14, while RYLPF trades at $27.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas RYLPF's P/E ratio is 23.29. In terms of profitability, MCRPF's ROE is +0.06%, compared to RYLPF's ROE of +0.09%. Regarding short-term risk, MCRPF and RYLPF have similar daily volatility (0.00).Check RYLPF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, SMMNY has a market cap of 22B. Regarding current trading prices, MCRPF is priced at $1.14, while SMMNY trades at $19.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas SMMNY's P/E ratio is 17.73. In terms of profitability, MCRPF's ROE is +0.06%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, MCRPF is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check SMMNY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, SONVY has a market cap of 13.5B. Regarding current trading prices, MCRPF is priced at $1.14, while SONVY trades at $45.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas SONVY's P/E ratio is 20.19. In terms of profitability, MCRPF's ROE is +0.06%, compared to SONVY's ROE of +0.20%. Regarding short-term risk, MCRPF is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check SONVY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, SONVF has a market cap of 13.4B. Regarding current trading prices, MCRPF is priced at $1.14, while SONVF trades at $224.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas SONVF's P/E ratio is 20.10. In terms of profitability, MCRPF's ROE is +0.06%, compared to SONVF's ROE of +0.20%. Regarding short-term risk, MCRPF is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check SONVF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, SNNUF has a market cap of 12.8B. Regarding current trading prices, MCRPF is priced at $1.14, while SNNUF trades at $14.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas SNNUF's P/E ratio is 20.76. In terms of profitability, MCRPF's ROE is +0.06%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, MCRPF and SNNUF have similar daily volatility (0.00).Check SNNUF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, WILYY has a market cap of 7.8B. Regarding current trading prices, MCRPF is priced at $1.14, while WILYY trades at $18.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas WILYY's P/E ratio is 21.10. In terms of profitability, MCRPF's ROE is +0.06%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, MCRPF is less volatile compared to WILYY. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check WILYY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, WILLF has a market cap of 7.2B. Regarding current trading prices, MCRPF is priced at $1.14, while WILLF trades at $34.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas WILLF's P/E ratio is 19.38. In terms of profitability, MCRPF's ROE is +0.06%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, MCRPF is less volatile compared to WILLF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check WILLF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, GNGBF has a market cap of 5.9B. Regarding current trading prices, MCRPF is priced at $1.14, while GNGBF trades at $23.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas GNGBF's P/E ratio is 25.25. In terms of profitability, MCRPF's ROE is +0.06%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, MCRPF and GNGBF have similar daily volatility (0.00).Check GNGBF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, GNGBY has a market cap of 5.7B. Regarding current trading prices, MCRPF is priced at $1.14, while GNGBY trades at $20.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas GNGBY's P/E ratio is 22.18. In terms of profitability, MCRPF's ROE is +0.06%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, MCRPF is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check GNGBY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, CHEOF has a market cap of 4.8B. Regarding current trading prices, MCRPF is priced at $1.14, while CHEOF trades at $73.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas CHEOF's P/E ratio is 19.30. In terms of profitability, MCRPF's ROE is +0.06%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, MCRPF and CHEOF have similar daily volatility (0.00).Check CHEOF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, CHEOY has a market cap of 4.8B. Regarding current trading prices, MCRPF is priced at $1.14, while CHEOY trades at $36.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas CHEOY's P/E ratio is 19.19. In terms of profitability, MCRPF's ROE is +0.06%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, MCRPF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check CHEOY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, AMBFF has a market cap of 3.4B. Regarding current trading prices, MCRPF is priced at $1.14, while AMBFF trades at $13.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas AMBFF's P/E ratio is 46.43. In terms of profitability, MCRPF's ROE is +0.06%, compared to AMBFF's ROE of +0.08%. Regarding short-term risk, MCRPF and AMBFF have similar daily volatility (0.00).Check AMBFF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, NHNKY has a market cap of 3B. Regarding current trading prices, MCRPF is priced at $1.14, while NHNKY trades at $9.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas NHNKY's P/E ratio is 13.24. In terms of profitability, MCRPF's ROE is +0.06%, compared to NHNKY's ROE of +0.07%. Regarding short-term risk, MCRPF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check NHNKY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, AMBBY has a market cap of 2.6B. Regarding current trading prices, MCRPF is priced at $1.14, while AMBBY trades at $9.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas AMBBY's P/E ratio is 34.91. In terms of profitability, MCRPF's ROE is +0.06%, compared to AMBBY's ROE of +0.08%. Regarding short-term risk, MCRPF and AMBBY have similar daily volatility (0.00).Check AMBBY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, GNNDY has a market cap of 2.2B. Regarding current trading prices, MCRPF is priced at $1.14, while GNNDY trades at $45.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas GNNDY's P/E ratio is 53.86. In terms of profitability, MCRPF's ROE is +0.06%, compared to GNNDY's ROE of -0.04%. Regarding short-term risk, MCRPF is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check GNNDY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, MCRPF is priced at $1.14, while OSSFF trades at $5.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas OSSFF's P/E ratio is 25.55. In terms of profitability, MCRPF's ROE is +0.06%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, MCRPF and OSSFF have similar daily volatility (0.00).Check OSSFF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, MCRPF is priced at $1.14, while DRWKF trades at $111.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas DRWKF's P/E ratio is 11.67. In terms of profitability, MCRPF's ROE is +0.06%, compared to DRWKF's ROE of +0.10%. Regarding short-term risk, MCRPF is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check DRWKF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, MCRPF is priced at $1.14, while GGNDF trades at $14.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas GGNDF's P/E ratio is 50.39. In terms of profitability, MCRPF's ROE is +0.06%, compared to GGNDF's ROE of -0.04%. Regarding short-term risk, MCRPF is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check GGNDF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, MCRPF is priced at $1.14, while DWRKF trades at $543.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, MCRPF's ROE is +0.06%, compared to DWRKF's ROE of N/A. Regarding short-term risk, MCRPF and DWRKF have similar daily volatility (0.00).Check DWRKF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, NHNKF has a market cap of 1.7B. Regarding current trading prices, MCRPF is priced at $1.14, while NHNKF trades at $10.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas NHNKF's P/E ratio is 30.28. In terms of profitability, MCRPF's ROE is +0.06%, compared to NHNKF's ROE of +0.07%. Regarding short-term risk, MCRPF and NHNKF have similar daily volatility (0.00).Check NHNKF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, MCRPF is priced at $1.14, while OSSUY trades at $4.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas OSSUY's P/E ratio is 20.05. In terms of profitability, MCRPF's ROE is +0.06%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, MCRPF and OSSUY have similar daily volatility (0.00).Check OSSUY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, STSEY has a market cap of 1.7B. Regarding current trading prices, MCRPF is priced at $1.14, while STSEY trades at $5.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas STSEY's P/E ratio is 18.37. In terms of profitability, MCRPF's ROE is +0.06%, compared to STSEY's ROE of -0.00%. Regarding short-term risk, MCRPF and STSEY have similar daily volatility (0.00).Check STSEY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, MCRPF is priced at $1.14, while MEDGF trades at $83.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, MCRPF's ROE is +0.06%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, MCRPF and MEDGF have similar daily volatility (0.00).Check MEDGF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, FDMDF has a market cap of 1.7B. Regarding current trading prices, MCRPF is priced at $1.14, while FDMDF trades at $2.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas FDMDF's P/E ratio is -9.66. In terms of profitability, MCRPF's ROE is +0.06%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, MCRPF is less volatile compared to FDMDF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check FDMDF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, MCRPF is priced at $1.14, while VTRLY trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas VTRLY's P/E ratio is -2.75. In terms of profitability, MCRPF's ROE is +0.06%, compared to VTRLY's ROE of -0.47%. Regarding short-term risk, MCRPF and VTRLY have similar daily volatility (0.00).Check VTRLY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, MCRPF is priced at $1.14, while MDRSF trades at $115.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas MDRSF's P/E ratio is 133.72. In terms of profitability, MCRPF's ROE is +0.06%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, MCRPF and MDRSF have similar daily volatility (0.00).Check MDRSF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, DGWPF has a market cap of 1.4B. Regarding current trading prices, MCRPF is priced at $1.14, while DGWPF trades at $72.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas DGWPF's P/E ratio is 7.53. In terms of profitability, MCRPF's ROE is +0.06%, compared to DGWPF's ROE of +0.10%. Regarding short-term risk, MCRPF and DGWPF have similar daily volatility (0.00).Check DGWPF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, MCRPF is priced at $1.14, while LFTSF trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, MCRPF's ROE is +0.06%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, MCRPF is less volatile compared to LFTSF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check LFTSF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, ELEAF has a market cap of 759.8M. Regarding current trading prices, MCRPF is priced at $1.14, while ELEAF trades at $9.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas ELEAF's P/E ratio is 12.99. In terms of profitability, MCRPF's ROE is +0.06%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, MCRPF is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check ELEAF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, XVIPF has a market cap of 603.2M. Regarding current trading prices, MCRPF is priced at $1.14, while XVIPF trades at $19.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas XVIPF's P/E ratio is 76.60. In terms of profitability, MCRPF's ROE is +0.06%, compared to XVIPF's ROE of +0.03%. Regarding short-term risk, MCRPF is less volatile compared to XVIPF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check XVIPF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, BRSYF has a market cap of 542.4M. Regarding current trading prices, MCRPF is priced at $1.14, while BRSYF trades at $13.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas BRSYF's P/E ratio is 75.28. In terms of profitability, MCRPF's ROE is +0.06%, compared to BRSYF's ROE of +0.11%. Regarding short-term risk, MCRPF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check BRSYF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, CALZF has a market cap of 514.1M. Regarding current trading prices, MCRPF is priced at $1.14, while CALZF trades at $0.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas CALZF's P/E ratio is 74.41. In terms of profitability, MCRPF's ROE is +0.06%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, MCRPF is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check CALZF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, IOBCF has a market cap of 501.5M. Regarding current trading prices, MCRPF is priced at $1.14, while IOBCF trades at $17.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas IOBCF's P/E ratio is 34.90. In terms of profitability, MCRPF's ROE is +0.06%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, MCRPF and IOBCF have similar daily volatility (0.00).Check IOBCF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, MCRPF is priced at $1.14, while AVMR trades at $9.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas AVMR's P/E ratio is -18.34. In terms of profitability, MCRPF's ROE is +0.06%, compared to AVMR's ROE of -0.30%. Regarding short-term risk, MCRPF and AVMR have similar daily volatility (0.00).Check AVMR's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, DMTRF has a market cap of 476M. Regarding current trading prices, MCRPF is priced at $1.14, while DMTRF trades at $3.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas DMTRF's P/E ratio is -198.00. In terms of profitability, MCRPF's ROE is +0.06%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, MCRPF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check DMTRF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, MCRPF is priced at $1.14, while HYBT trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas HYBT's P/E ratio is N/A. In terms of profitability, MCRPF's ROE is +0.06%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, MCRPF and HYBT have similar daily volatility (0.00).Check HYBT's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, CLVSF has a market cap of 321.8M. Regarding current trading prices, MCRPF is priced at $1.14, while CLVSF trades at $13.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas CLVSF's P/E ratio is 22.11. In terms of profitability, MCRPF's ROE is +0.06%, compared to CLVSF's ROE of +0.15%. Regarding short-term risk, MCRPF is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check CLVSF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, CYBQY has a market cap of 303.2M. Regarding current trading prices, MCRPF is priced at $1.14, while CYBQY trades at $1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas CYBQY's P/E ratio is -170.00. In terms of profitability, MCRPF's ROE is +0.06%, compared to CYBQY's ROE of -0.00%. Regarding short-term risk, MCRPF and CYBQY have similar daily volatility (0.00).Check CYBQY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, CSSPF has a market cap of 273.5M. Regarding current trading prices, MCRPF is priced at $1.14, while CSSPF trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas CSSPF's P/E ratio is 32.50. In terms of profitability, MCRPF's ROE is +0.06%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, MCRPF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check CSSPF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, MCRPF is priced at $1.14, while HTLZF trades at $1.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, MCRPF's ROE is +0.06%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, MCRPF and HTLZF have similar daily volatility (0.00).Check HTLZF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, IMPZY has a market cap of 229.3M. Regarding current trading prices, MCRPF is priced at $1.14, while IMPZY trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, MCRPF's ROE is +0.06%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, MCRPF and IMPZY have similar daily volatility (0.00).Check IMPZY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, CYBQF has a market cap of 206.8M. Regarding current trading prices, MCRPF is priced at $1.14, while CYBQF trades at $1.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas CYBQF's P/E ratio is -155.00. In terms of profitability, MCRPF's ROE is +0.06%, compared to CYBQF's ROE of -0.00%. Regarding short-term risk, MCRPF and CYBQF have similar daily volatility (0.00).Check CYBQF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, MCRPF is priced at $1.14, while VMTHF trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, MCRPF's ROE is +0.06%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, MCRPF and VMTHF have similar daily volatility (0.00).Check VMTHF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, BCCOY has a market cap of 183.5M. Regarding current trading prices, MCRPF is priced at $1.14, while BCCOY trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas BCCOY's P/E ratio is -1.14. In terms of profitability, MCRPF's ROE is +0.06%, compared to BCCOY's ROE of -0.51%. Regarding short-term risk, MCRPF and BCCOY have similar daily volatility (0.00).Check BCCOY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, MCRPF is priced at $1.14, while DTXMF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, MCRPF's ROE is +0.06%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, MCRPF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check DTXMF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, EKDHF has a market cap of 167.9M. Regarding current trading prices, MCRPF is priced at $1.14, while EKDHF trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas EKDHF's P/E ratio is 39.00. In terms of profitability, MCRPF's ROE is +0.06%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, MCRPF and EKDHF have similar daily volatility (0.00).Check EKDHF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, EAPIF has a market cap of 162.8M. Regarding current trading prices, MCRPF is priced at $1.14, while EAPIF trades at $1.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas EAPIF's P/E ratio is -0.65. In terms of profitability, MCRPF's ROE is +0.06%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, MCRPF and EAPIF have similar daily volatility (0.00).Check EAPIF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, BRNHF has a market cap of 161.7M. Regarding current trading prices, MCRPF is priced at $1.14, while BRNHF trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, MCRPF's ROE is +0.06%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, MCRPF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check BRNHF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, CLLKF has a market cap of 136.8M. Regarding current trading prices, MCRPF is priced at $1.14, while CLLKF trades at $1.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas CLLKF's P/E ratio is -0.88. In terms of profitability, MCRPF's ROE is +0.06%, compared to CLLKF's ROE of -0.52%. Regarding short-term risk, MCRPF and CLLKF have similar daily volatility (0.00).Check CLLKF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, MCRPF is priced at $1.14, while AMEUF trades at $5.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, MCRPF's ROE is +0.06%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, MCRPF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check AMEUF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, PXMBF has a market cap of 119.9M. Regarding current trading prices, MCRPF is priced at $1.14, while PXMBF trades at $2.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, MCRPF's ROE is +0.06%, compared to PXMBF's ROE of -0.04%. Regarding short-term risk, MCRPF is less volatile compared to PXMBF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check PXMBF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, SNZZF has a market cap of 110.1M. Regarding current trading prices, MCRPF is priced at $1.14, while SNZZF trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas SNZZF's P/E ratio is -7.78. In terms of profitability, MCRPF's ROE is +0.06%, compared to SNZZF's ROE of -0.38%. Regarding short-term risk, MCRPF and SNZZF have similar daily volatility (0.00).Check SNZZF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, AVHHL has a market cap of 102.7M. Regarding current trading prices, MCRPF is priced at $1.14, while AVHHL trades at $0.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas AVHHL's P/E ratio is -2.36. In terms of profitability, MCRPF's ROE is +0.06%, compared to AVHHL's ROE of +4.77%. Regarding short-term risk, MCRPF and AVHHL have similar daily volatility (0.00).Check AVHHL's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, SOMNF has a market cap of 98.6M. Regarding current trading prices, MCRPF is priced at $1.14, while SOMNF trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas SOMNF's P/E ratio is -45.00. In terms of profitability, MCRPF's ROE is +0.06%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, MCRPF and SOMNF have similar daily volatility (0.00).Check SOMNF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, JMDMF has a market cap of 94.1M. Regarding current trading prices, MCRPF is priced at $1.14, while JMDMF trades at $3.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas JMDMF's P/E ratio is -13.68. In terms of profitability, MCRPF's ROE is +0.06%, compared to JMDMF's ROE of N/A. Regarding short-term risk, MCRPF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check JMDMF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, MCRPF is priced at $1.14, while RSHUF trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, MCRPF's ROE is +0.06%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, MCRPF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check RSHUF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, MCRPF is priced at $1.14, while CKMTF trades at $12.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, MCRPF's ROE is +0.06%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, MCRPF and CKMTF have similar daily volatility (0.00).Check CKMTF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, BLOZF has a market cap of 64.7M. Regarding current trading prices, MCRPF is priced at $1.14, while BLOZF trades at $0.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas BLOZF's P/E ratio is -13.20. In terms of profitability, MCRPF's ROE is +0.06%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, MCRPF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check BLOZF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, TLTFF has a market cap of 54.9M. Regarding current trading prices, MCRPF is priced at $1.14, while TLTFF trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas TLTFF's P/E ratio is -19.90. In terms of profitability, MCRPF's ROE is +0.06%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, MCRPF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check TLTFF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, MCRPF is priced at $1.14, while NVYTF trades at $0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, MCRPF's ROE is +0.06%, compared to NVYTF's ROE of -1.25%. Regarding short-term risk, MCRPF and NVYTF have similar daily volatility (0.00).Check NVYTF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, RDGL has a market cap of 29.9M. Regarding current trading prices, MCRPF is priced at $1.14, while RDGL trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas RDGL's P/E ratio is -6.20. In terms of profitability, MCRPF's ROE is +0.06%, compared to RDGL's ROE of -1.26%. Regarding short-term risk, MCRPF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check RDGL's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, POSC has a market cap of 26.1M. Regarding current trading prices, MCRPF is priced at $1.14, while POSC trades at $1.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas POSC's P/E ratio is -5.38. In terms of profitability, MCRPF's ROE is +0.06%, compared to POSC's ROE of -4.69%. Regarding short-term risk, MCRPF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check POSC's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, MCRPF is priced at $1.14, while MKEAF trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, MCRPF's ROE is +0.06%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, MCRPF and MKEAF have similar daily volatility (0.00).Check MKEAF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, MCRPF is priced at $1.14, while TCLIF trades at $0.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas TCLIF's P/E ratio is -4.84. In terms of profitability, MCRPF's ROE is +0.06%, compared to TCLIF's ROE of +2.39%. Regarding short-term risk, MCRPF is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check TCLIF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, PYNKF has a market cap of 24.9M. Regarding current trading prices, MCRPF is priced at $1.14, while PYNKF trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas PYNKF's P/E ratio is 3.96. In terms of profitability, MCRPF's ROE is +0.06%, compared to PYNKF's ROE of -2.78%. Regarding short-term risk, MCRPF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check PYNKF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, MCRPF is priced at $1.14, while KBBTF trades at $0.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, MCRPF's ROE is +0.06%, compared to KBBTF's ROE of N/A. Regarding short-term risk, MCRPF and KBBTF have similar daily volatility (0.00).Check KBBTF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, EMITF has a market cap of 21.3M. Regarding current trading prices, MCRPF is priced at $1.14, while EMITF trades at $1.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas EMITF's P/E ratio is -7.62. In terms of profitability, MCRPF's ROE is +0.06%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, MCRPF and EMITF have similar daily volatility (0.00).Check EMITF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, VPTDF has a market cap of 18.5M. Regarding current trading prices, MCRPF is priced at $1.14, while VPTDF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas VPTDF's P/E ratio is -4.94. In terms of profitability, MCRPF's ROE is +0.06%, compared to VPTDF's ROE of +0.78%. Regarding short-term risk, MCRPF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check VPTDF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, MCRPF is priced at $1.14, while DIZTF trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, MCRPF's ROE is +0.06%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, MCRPF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check DIZTF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, GTHP has a market cap of 16.9M. Regarding current trading prices, MCRPF is priced at $1.14, while GTHP trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas GTHP's P/E ratio is -5.50. In terms of profitability, MCRPF's ROE is +0.06%, compared to GTHP's ROE of +0.82%. Regarding short-term risk, MCRPF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check GTHP's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, IPDQF has a market cap of 16.3M. Regarding current trading prices, MCRPF is priced at $1.14, while IPDQF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas IPDQF's P/E ratio is -0.80. In terms of profitability, MCRPF's ROE is +0.06%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, MCRPF and IPDQF have similar daily volatility (0.00).Check IPDQF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, MCRPF is priced at $1.14, while MDXHF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, MCRPF's ROE is +0.06%, compared to MDXHF's ROE of +0.66%. Regarding short-term risk, MCRPF and MDXHF have similar daily volatility (0.00).Check MDXHF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, ASAPF has a market cap of 14.1M. Regarding current trading prices, MCRPF is priced at $1.14, while ASAPF trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas ASAPF's P/E ratio is -18.12. In terms of profitability, MCRPF's ROE is +0.06%, compared to ASAPF's ROE of -0.19%. Regarding short-term risk, MCRPF is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check ASAPF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, MCRPF is priced at $1.14, while TMDIF trades at $0.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, MCRPF's ROE is +0.06%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, MCRPF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check TMDIF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, MCRPF is priced at $1.14, while ATBPF trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, MCRPF's ROE is +0.06%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, MCRPF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check ATBPF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, MCRPF is priced at $1.14, while LXXGF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, MCRPF's ROE is +0.06%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, MCRPF and LXXGF have similar daily volatility (0.00).Check LXXGF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, ALRTF has a market cap of 9.7M. Regarding current trading prices, MCRPF is priced at $1.14, while ALRTF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas ALRTF's P/E ratio is -0.38. In terms of profitability, MCRPF's ROE is +0.06%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, MCRPF and ALRTF have similar daily volatility (0.00).Check ALRTF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, MCRPF is priced at $1.14, while PLLWF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, MCRPF's ROE is +0.06%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, MCRPF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check PLLWF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, PMEDF has a market cap of 7.3M. Regarding current trading prices, MCRPF is priced at $1.14, while PMEDF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas PMEDF's P/E ratio is -3.53. In terms of profitability, MCRPF's ROE is +0.06%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, MCRPF is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check PMEDF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, BIEL has a market cap of 7.2M. Regarding current trading prices, MCRPF is priced at $1.14, while BIEL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas BIEL's P/E ratio is N/A. In terms of profitability, MCRPF's ROE is +0.06%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, MCRPF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check BIEL's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, USAQ has a market cap of 6.3M. Regarding current trading prices, MCRPF is priced at $1.14, while USAQ trades at $0.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas USAQ's P/E ratio is 28.02. In terms of profitability, MCRPF's ROE is +0.06%, compared to USAQ's ROE of -8.25%. Regarding short-term risk, MCRPF and USAQ have similar daily volatility (0.00).Check USAQ's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, RMSL has a market cap of 5.7M. Regarding current trading prices, MCRPF is priced at $1.14, while RMSL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas RMSL's P/E ratio is 0.34. In terms of profitability, MCRPF's ROE is +0.06%, compared to RMSL's ROE of -17961324.55%. Regarding short-term risk, MCRPF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check RMSL's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, ADMT has a market cap of 5.6M. Regarding current trading prices, MCRPF is priced at $1.14, while ADMT trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas ADMT's P/E ratio is -8.35. In terms of profitability, MCRPF's ROE is +0.06%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, MCRPF is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check ADMT's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, MCRPF is priced at $1.14, while QLIS trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas QLIS's P/E ratio is 2.22. In terms of profitability, MCRPF's ROE is +0.06%, compared to QLIS's ROE of -0.77%. Regarding short-term risk, MCRPF and QLIS have similar daily volatility (0.00).Check QLIS's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, MCRPF is priced at $1.14, while RHNMF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, MCRPF's ROE is +0.06%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, MCRPF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check RHNMF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, ODYY has a market cap of 5M. Regarding current trading prices, MCRPF is priced at $1.14, while ODYY trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas ODYY's P/E ratio is -1.00. In terms of profitability, MCRPF's ROE is +0.06%, compared to ODYY's ROE of +0.58%. Regarding short-term risk, MCRPF is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check ODYY's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, MCRPF is priced at $1.14, while VANIW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas VANIW's P/E ratio is N/A. In terms of profitability, MCRPF's ROE is +0.06%, compared to VANIW's ROE of -3.17%. Regarding short-term risk, MCRPF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check VANIW's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, CYDX has a market cap of 3.2M. Regarding current trading prices, MCRPF is priced at $1.14, while CYDX trades at $0.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas CYDX's P/E ratio is 0.79. In terms of profitability, MCRPF's ROE is +0.06%, compared to CYDX's ROE of +0.13%. Regarding short-term risk, MCRPF and CYDX have similar daily volatility (0.00).Check CYDX's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, LLBO has a market cap of 3M. Regarding current trading prices, MCRPF is priced at $1.14, while LLBO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas LLBO's P/E ratio is N/A. In terms of profitability, MCRPF's ROE is +0.06%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, MCRPF is less volatile compared to LLBO. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check LLBO's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, TBRIF has a market cap of 2.8M. Regarding current trading prices, MCRPF is priced at $1.14, while TBRIF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas TBRIF's P/E ratio is -0.96. In terms of profitability, MCRPF's ROE is +0.06%, compared to TBRIF's ROE of +2.92%. Regarding short-term risk, MCRPF and TBRIF have similar daily volatility (0.00).Check TBRIF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, NGMDF has a market cap of 2.4M. Regarding current trading prices, MCRPF is priced at $1.14, while NGMDF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas NGMDF's P/E ratio is -1.04. In terms of profitability, MCRPF's ROE is +0.06%, compared to NGMDF's ROE of +0.94%. Regarding short-term risk, MCRPF and NGMDF have similar daily volatility (0.00).Check NGMDF's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, VYCO has a market cap of 2.3M. Regarding current trading prices, MCRPF is priced at $1.14, while VYCO trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas VYCO's P/E ratio is -7.00. In terms of profitability, MCRPF's ROE is +0.06%, compared to VYCO's ROE of +0.02%. Regarding short-term risk, MCRPF is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check VYCO's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, KLYG has a market cap of 2.2M. Regarding current trading prices, MCRPF is priced at $1.14, while KLYG trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas KLYG's P/E ratio is -17.68. In terms of profitability, MCRPF's ROE is +0.06%, compared to KLYG's ROE of -0.19%. Regarding short-term risk, MCRPF is less volatile compared to KLYG. This indicates potentially lower risk in terms of short-term price fluctuations for MCRPF.Check KLYG's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, FZMD has a market cap of 2M. Regarding current trading prices, MCRPF is priced at $1.14, while FZMD trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas FZMD's P/E ratio is 1.35. In terms of profitability, MCRPF's ROE is +0.06%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, MCRPF and FZMD have similar daily volatility (0.00).Check FZMD's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, NUMD has a market cap of 1.5M. Regarding current trading prices, MCRPF is priced at $1.14, while NUMD trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas NUMD's P/E ratio is 1.74. In terms of profitability, MCRPF's ROE is +0.06%, compared to NUMD's ROE of +0.22%. Regarding short-term risk, MCRPF and NUMD have similar daily volatility (0.00).Check NUMD's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, ESMC has a market cap of 1.3M. Regarding current trading prices, MCRPF is priced at $1.14, while ESMC trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas ESMC's P/E ratio is -5.67. In terms of profitability, MCRPF's ROE is +0.06%, compared to ESMC's ROE of -125.28%. Regarding short-term risk, MCRPF and ESMC have similar daily volatility (0.00).Check ESMC's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, UAHC has a market cap of 777.5K. Regarding current trading prices, MCRPF is priced at $1.14, while UAHC trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas UAHC's P/E ratio is 0.56. In terms of profitability, MCRPF's ROE is +0.06%, compared to UAHC's ROE of +0.04%. Regarding short-term risk, MCRPF and UAHC have similar daily volatility (0.00).Check UAHC's competition here

MCRPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCRPF stands at 2.2B. In comparison, ELXMF has a market cap of 541.2K. Regarding current trading prices, MCRPF is priced at $1.14, while ELXMF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCRPF currently has a P/E ratio of -12.67, whereas ELXMF's P/E ratio is -0.09. In terms of profitability, MCRPF's ROE is +0.06%, compared to ELXMF's ROE of -0.40%. Regarding short-term risk, MCRPF and ELXMF have similar daily volatility (0.00).Check ELXMF's competition here